By Devika Patel
Knoxville, Tenn., Dec. 11 - RegeneRx Biopharmaceuticals, Inc. said it raised $3 million from a private placement of shares with two affiliates of the company's largest shareholder, Sigma-Tau Group.
The company sold 2,068,964 common shares at $1.45 per share.
Investors also received warrants for 745,104 common shares. The warrants are exercisable at $1.74 per share.
Based in Bethesda, Md., RegeneRx is a biopharmaceutical company focused on the treatment of acute and chronic wounds.
| Issuer: | RegeneRx Biopharmaceuticals, Inc.
|
| Issue: | Common shares
|
| Amount: | $3 million
|
| Shares: | 2,068,964
|
| Price: | $1.45
|
| Warrants: | For 745,104 shares
|
| Warrant strike price: | $1.74
|
| Investors: | Affiliates of Sigma-Tau Group
|
| Settlement date: | Dec. 11
|
| Stock symbol: | Amex: RGN
|
| Stock price: | $1.40 at close Dec. 10
|
| Market capitalization: | $74.8 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
